{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T13:02:09Z","timestamp":1765976529688},"reference-count":33,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2021,11,23]],"date-time":"2021-11-23T00:00:00Z","timestamp":1637625600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,11,23]],"date-time":"2021-11-23T00:00:00Z","timestamp":1637625600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Br Dent J"],"DOI":"10.1038\/s41415-021-3620-9","type":"journal-article","created":{"date-parts":[[2021,11,23]],"date-time":"2021-11-23T17:16:03Z","timestamp":1637687763000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["The incidence of medication-related osteonecrosis of the jaw following tooth extraction in patients prescribed oral bisphosphonates"],"prefix":"10.1038","author":[{"given":"Elizabeth","family":"Barry","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Talli","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jashme","family":"Patel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Umar","family":"Hamid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cathy","family":"Bryant","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,11,23]]},"reference":[{"key":"3620_CR5876","doi-asserted-by":"crossref","unstructured":"Drake M T, Clarke B L, Khosla S. Bisphosphonates: mechanism of action and role in clinical practice. Mayo Clin Proc 2008; 83: 1032-1045.","DOI":"10.4065\/83.9.1032"},{"key":"3620_CR5878","doi-asserted-by":"crossref","unstructured":"Watts N B. Bisphosphonate treatment of osteoporosis. Clin Geriatr Med 2003; 19: 395-414.","DOI":"10.1016\/S0749-0690(02)00069-1"},{"key":"3620_CR5880","unstructured":"NICE. Early breast cancer (preventing recurrence and improving survival): adjuvant bisphosphonates. 2017. Available at https:\/\/www.nice.org.uk\/advice\/es15\/chapter\/Key-points (accessed November 2020)."},{"key":"3620_CR5883","unstructured":"Medicines and Healthcare products Regulatory Agency. Bisphosphonates: Use and Safety. 2014. Available at https:\/\/www.gov.uk\/government\/publications\/bisphosphonates-use-and-safety (accessed November 2020)."},{"key":"3620_CR5887","unstructured":"European Medicines Agency. Assessment report for bisphosphonates containing medicinal products. 2011. Available at https:\/\/www.ema.europa.eu\/en\/documents\/referral\/assessment-report-bisphosphonates-containing-medicinal-products_en.pdf (accessed November 2020)."},{"key":"3620_CR5891","unstructured":"Medicines and Healthcare products Regulatory Agency. Bisphosphonates: atypical femoral fractures. 2014. Available at https:\/\/www.gov.uk\/drug-safety-update\/bisphosphonates-atypical-femoral-fractures (accessed November 2020)."},{"key":"3620_CR5894","unstructured":"Medicines and Healthcare products Regulatory Agency. Bisphosphonates: very rare reports of osteonecrosis of the external auditory canal. 2015. Available at https:\/\/www.gov.uk\/drug-safety-update\/bisphosphonates-very-rare-reports-of-osteonecrosis-of-the-external-auditory-canal (accessed November 2020)."},{"key":"3620_CR5897","doi-asserted-by":"crossref","unstructured":"Ruggiero S L, Dodson T B, Fantasia J et al. American Association of Oral and Maxillofacial Surgeons Position Paper on Medication-Related Osteonecrosis of the Jaw - 2014 Update. J Oral Maxillofac Surg 2014; 72: 1938-1956.","DOI":"10.1016\/j.joms.2014.04.031"},{"key":"3620_CR5899","doi-asserted-by":"crossref","unstructured":"Beth-Tasdogan N H, Mayer B, Hussein H, Zolk O. Interventions for managing medication-related osteonecrosis of the jaw. Cochrane Database Syst Rev 2017; DOI: 10.1002\/14651858.CD012432.pub2.","DOI":"10.1002\/14651858.CD012432"},{"key":"3620_CR5901","doi-asserted-by":"crossref","unstructured":"King R, Zebic L, Patel V. Deciphering novel chemotherapy and its impact on dentistry. Br Dent J 2020; 228: 415-421.","DOI":"10.1038\/s41415-020-1365-5"},{"key":"3620_CR5903","doi-asserted-by":"crossref","unstructured":"Schiodt M, Otto S, Fedele S et al. Workshop of European task force on medication-related osteonecrosis of the jaw - Current challenges. Oral Dis 2019; 25: 1815-1821.","DOI":"10.1111\/odi.13160"},{"key":"3620_CR5906","unstructured":"Scottish Dental Clinical Effectiveness Programme. Oral health management of patients at risk of medication-related osteonecrosis of the jaw. Dental Clinical Guidance. 2017. Available at https:\/\/www.sdcep.org.uk\/published-guidance\/medication-related-osteonecrosis-of-the-jaw\/ (accessed November 2020)."},{"key":"3620_CR5909","doi-asserted-by":"crossref","unstructured":"Mavrokokki T, Cheng A, Stein B, Goss A. Nature and Frequency of Bisphosphonate - Associated Osteonecrosis of the Jaws in Australia. J Oral Maxillofac Surg 2007; 65: 415-423.","DOI":"10.1016\/j.joms.2006.10.061"},{"key":"3620_CR5911","doi-asserted-by":"crossref","unstructured":"Jeong H G, Hwang J J, Lee J H, Kim Y H, Na J Y, Han S S. Risk factors of osteonecrosis of the jaw after tooth extraction in osteoporotic patients on oral bisphosphonates. Imaging Sci Dent 2017; 47: 45-50.","DOI":"10.5624\/isd.2017.47.1.45"},{"key":"3620_CR5913","doi-asserted-by":"crossref","unstructured":"Taylor T, Bryant C, Popat S. A study of 225 patients on bisphosphonates presenting to the bisphosphonate clinic at King's College Hospital. Br Dent J 2013; DOI: 10.1038\/sj.bdj.2013.327.","DOI":"10.1038\/sj.bdj.2013.327"},{"key":"3620_CR5915","doi-asserted-by":"crossref","unstructured":"Shudo A, Kishimoto H, Takaoka K, Noguchi K. Long-term oral bisphosphonates delay healing after tooth extraction: a single institutional prospective study. Osteoporos Int 2018; 29: 2315-2321.","DOI":"10.1007\/s00198-018-4621-7"},{"key":"3620_CR5918","doi-asserted-by":"crossref","unstructured":"Gaudin E, Seidel L, Bacevic M, Rompen E, Lambert F. Occurrence and risk indicators of medication-related osteonecrosis of the jaw after dental extraction: A systematic review and meta-analysis. J Clin Periodontol 2015; 42: 922-932.","DOI":"10.1111\/jcpe.12455"},{"key":"3620_CR5920","doi-asserted-by":"crossref","unstructured":"Mozzati M, Arata V, Gallesio G. Tooth extraction in osteoporotic patients taking oral bisphosphonates. Osteoporos Int 2013; 24: 1707-1712.","DOI":"10.1007\/s00198-012-2239-8"},{"key":"3620_CR5922","doi-asserted-by":"crossref","unstructured":"Kunchur R, Need A, Hughes T, Goss A. Clinical investigation of C-terminal crosslinking telopeptide test in prevention and management of bisphosphonate-associated osteonecrosis of the jaws. J Oral Maxillofac Surg 2009; 67: 1167-1173.","DOI":"10.1016\/j.joms.2009.02.004"},{"key":"3620_CR5924","doi-asserted-by":"crossref","unstructured":"Hasegawa T, Kawakita A, Ueda N et al. A multicentre retrospective study of the risk factors associated with medication-related osteonecrosis of the jaw after tooth extraction in patients receiving oral bisphosphonate therapy: can primary wound closure and a drug holiday really prevent MRONJ? Osteoporos Int 2017; 28: 2465-2473.","DOI":"10.1007\/s00198-017-4063-7"},{"key":"3620_CR5928","doi-asserted-by":"crossref","unstructured":"Dodson T B. The Frequency of Medication-related Osteonecrosis of the Jaw and its Associated Risk Factors. Oral Maxillofac Surg Clin North Am 2015; 27: 509-516.","DOI":"10.1016\/j.coms.2015.06.003"},{"key":"3620_CR5930","doi-asserted-by":"crossref","unstructured":"Chiu W Y, Yang W S, Chien J Y, Lee J J, Tsai K S. The influence of alendronate and tooth extraction on the incidence of osteonecrosis of the jaw among osteoporotic subjects. PLoS One 2018; DOI: 10.1371\/journal.pone.0196419.","DOI":"10.1371\/journal.pone.0196419"},{"key":"3620_CR5932","doi-asserted-by":"crossref","unstructured":"Bagan J V, Jimenez Y, Murillo J et al. Jaw osteonecrosis associated with bisphosphonates: multiple exposed areas and its relationship to teeth extractions. Study of 20 cases. Oral Oncol 2006; 42: 327-329.","DOI":"10.1016\/j.oraloncology.2005.08.001"},{"key":"3620_CR5934","doi-asserted-by":"crossref","unstructured":"McGowan K, Ware R S, Acton C, Ivanovski S, Johnson N W. Both non-surgical dental treatment and extractions increase the risk of medication-related osteonecrosis of the jaw: case-control study. Clin Oral Investig 2019; 23: 3967-3975.","DOI":"10.1007\/s00784-019-02828-w"},{"key":"3620_CR5936","doi-asserted-by":"crossref","unstructured":"Khosla S, Burr D, Cauley J et al. Bisphosphonate-associated osteonecrosis of the jaw: report of a task force of the American Society for Bone and Mineral Research. J Bone Miner Res 2007; 22: 1479-1491.","DOI":"10.1359\/jbmr.0707onj"},{"key":"3620_CR5939","doi-asserted-by":"crossref","unstructured":"Lo J C, O'Ryan F S, Gordon N P et al. Prevalence of osteonecrosis of the jaw in patients with oral bisphosphonate exposure. J Oral Maxillofac Surg 2010; 68: 243-253.","DOI":"10.1016\/j.joms.2009.03.050"},{"key":"3620_CR5941","doi-asserted-by":"crossref","unstructured":"Saad F, Brown J E, Van Poznak C et al. Incidence, risk factors, and outcomes of osteonecrosis of the jaw: integrated analysis from three blinded active-controlled phase III trials in cancer patients with bone metastases. Ann Oncol 2012; 23: 1341-1347.","DOI":"10.1093\/annonc\/mdr435"},{"key":"3620_CR5943","doi-asserted-by":"crossref","unstructured":"Nicolatou-Galitis O, Schi\u00f8dt M, Mendes R A et al. Medication-related osteonecrosis of the jaw: definition and best practice for prevention, diagnosis, and treatment. Oral Surg Oral Med Oral Pathol Oral Radiol 2019; 127: 117-135.","DOI":"10.1016\/j.oooo.2018.09.008"},{"key":"3620_CR5946","doi-asserted-by":"crossref","unstructured":"Ulmner M, Jarnbring F, T\u00f6rring O. Osteonecrosis of the jaw in Sweden associated with the oral use of bisphosphonate. J Oral Maxillofac Surg 2014; 72: 76-82.","DOI":"10.1016\/j.joms.2013.06.221"},{"key":"3620_CR5948","unstructured":"Fleisher K E, Kontio R, Otto S. Antiresorptive drug-related osteonecrosis of the jaw (ARONJ) - a guide to research. Switzerland: AO Foundation, 2016."},{"key":"3620_CR5951","doi-asserted-by":"crossref","unstructured":"Tanna N, Steel C, Stagnell S, Bailey E. Awareness of medication related osteonecrosis of the jaws (MRONJ) among general dental practitioners. Br Dent J 2017; 222: 121-125.","DOI":"10.1038\/sj.bdj.2017.79"},{"key":"3620_CR5953","unstructured":"Berm\u00fadez-Bejarano E B, Serrera-Figallo M \u00c1, Guti\u00e9rrez-Corrales A et al. Prophylaxis and antibiotic therapy in management protocols of patients treated with oral and intravenous bisphosphonates. J Clin Exp Dent 2017; DOI: 10.4317\/jced.53372."},{"key":"3620_CR5955","doi-asserted-by":"crossref","unstructured":"Hellstein J W, Adler R A, Edwards B et al. Managing the care of patients receiving antiresorptive therapy for prevention and treatment of osteoporosis: executive summary of recommendations from the American Dental Association Council on Scientific Affairs. J Am Dent Assoc 2011; 142: 1243-1251.","DOI":"10.14219\/jada.archive.2011.0108"}],"container-title":["British Dental Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41415-021-3620-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41415-021-3620-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41415-021-3620-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,23]],"date-time":"2021-11-23T17:17:33Z","timestamp":1637687853000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41415-021-3620-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,23]]},"references-count":33,"alternative-id":["3620"],"URL":"https:\/\/doi.org\/10.1038\/s41415-021-3620-9","relation":{},"ISSN":["0007-0610","1476-5373"],"issn-type":[{"value":"0007-0610","type":"print"},{"value":"1476-5373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,23]]},"assertion":[{"value":"23 December 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 February 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 November 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authorship confirms that there is no conflict of interest and no outside sources of funding have been received.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics declaration"}}]}}